{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:39:03Z","timestamp":1784835543425,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The World Health Organization category of myeloid\/lymphoid neoplasms with eosinophilia and PDGFRA rearrangements is composed of a heterogeneous group of neoplasms that can present as a myeloproliferative neoplasm, acute myeloid leukemia, myeloid sarcoma, or lymphoblastic leukemia\/lymphoma. The overall outcome of these neoplasms is favorable with imatinib therapy. Herein, we describe an adult female patient with a myeloid neoplasm accompanied by eosinophilia and a novel USP25::PDGFRA gene fusion.<\/jats:p>","DOI":"10.1093\/labmed\/lmac010","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T20:12:39Z","timestamp":1643314359000},"page":"e134-e138","source":"Crossref","is-referenced-by-count":4,"title":["A Novel <i>USP25::PDGFRA<\/i> Gene Fusion in a 78 Year Old Patient with a Myeloid Neoplasm"],"prefix":"10.1093","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6856-7746","authenticated-orcid":false,"given":"Joanna C","family":"Dalland","sequence":"first","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R","family":"Blackburn","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaaren K","family":"Reichard","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Johnson","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Smadbeck","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vasmatzis","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L","family":"Hoppman","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T","family":"Greipp","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B","family":"Baughn","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess F","family":"Peterson","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"key":"2022090114000340100_CIT0001","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"4"},{"key":"2022090114000340100_CIT0002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcp\/aqaa208","article-title":"Myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2","volume":"155","author":"Pozdnyakova","year":"2021","journal-title":"Am J Clin Pathol."},{"key":"2022090114000340100_CIT0003","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1309\/AJCPMORR5Z2IKCEM","article-title":"Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1","volume":"144","author":"Vega","year":"2015","journal-title":"Am J Clin Pathol."},{"key":"2022090114000340100_CIT0004","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/bioinformatics\/btu078","article-title":"BIMA V3: an aligner customized for mate pair library sequencing","volume":"30","author":"Drucker","year":"2014","journal-title":"Bioinformatics."},{"key":"2022090114000340100_CIT0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2017.11.009","article-title":"SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)","volume":"221","author":"Johnson","year":"2018","journal-title":"Cancer Genet."},{"key":"2022090114000340100_CIT0006","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"2022090114000340100_CIT0007","doi-asserted-by":"crossref","first-page":"698751","DOI":"10.3389\/fcell.2021.698751","article-title":"Emerging roles of ubiquitin-specific protease 25 in diseases","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"2022090114000340100_CIT0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/leu.2008.310","article-title":"The molecular anatomy of the FIP1L1-PDGFRA fusion gene","volume":"23","author":"Walz","year":"2009","journal-title":"Leukemia."},{"key":"2022090114000340100_CIT0009","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.3324\/haematol.2017.187302","article-title":"Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2","volume":"103","author":"Baer","year":"2018","journal-title":"Haematologica."},{"key":"2022090114000340100_CIT0010","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1002\/ajh.24273","article-title":"Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol."},{"key":"2022090114000340100_CIT0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood."},{"key":"2022090114000340100_CIT0012","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med."},{"key":"2022090114000340100_CIT0013","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1532\/IJH97.05048","article-title":"Chronic eosinophilic leukemia with the FIP1L1-PDGFRalpha fusion gene in a patient with a history of combination chemotherapy","volume":"83","author":"Tanaka","year":"2006","journal-title":"Int J Hematol."},{"key":"2022090114000340100_CIT0014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gcc.20014","article-title":"Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia","volume":"40","author":"Safley","year":"2004","journal-title":"Genes Chromosomes Cancer."},{"key":"2022090114000340100_CIT0015","first-page":"5812","article-title":"Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature","volume":"8","author":"Zhou","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"2022090114000340100_CIT0016","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/leu.2012.162","article-title":"Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome","volume":"26","author":"Pardanani","year":"2012","journal-title":"Leukemia."},{"key":"2022090114000340100_CIT0017","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","article-title":"FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature","volume":"30","author":"Pardanani","year":"2006","journal-title":"Leuk Res."},{"key":"2022090114000340100_CIT0018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2021 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am J Hematol."},{"key":"2022090114000340100_CIT0019","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/5\/e134\/45640181\/lmac010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/53\/5\/e134\/45640181\/lmac010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T14:58:44Z","timestamp":1662044324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/53\/5\/e134\/6537356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,2,26]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmac010","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,2,26]]}}}